ArticlePharmaceuticals (Basel, Switzerland)2022

Impact of Repeated Doses of Subcutaneous Esketamine on Acute Dissociative Symptoms in Treatment-Resistant Depression.

Lorena Catarina Del Sant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.